Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.79
Price to sales ratio
5.86

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3268
MOVE
Corvex, Inc. - Common Stock
11.49 USD+2.96%+30.27%-0.69%+1148.91%317.67 M USD
3312
TMCI
Treace Medical Concepts, Inc. - Common Stock
4.65 USD+1.09%+5.92%+15.96%-37.42%302.41 M USD
3330
CV
CapsoVision, Inc. - Common Stock
5.93 USD-2.15%-1.98%-10.42%+48.62%296.78 M USD
3341
RXST
RxSight, Inc. - Common Stock
7.05 USD+6.66%+12.62%+17.50%-22.87%293.23 M USD

Frequently asked questions about TriSalus Life Sciences, Inc. Common Stock

What is the TriSalus Life Sciences, Inc. Common Stock stock price today?

The current price of TriSalus Life Sciences, Inc. Common Stock (TLSI) is 4.83. Over the past 24 hours, the stock has changed by -2.03%. Follow the TLSI chart for real-time price dynamics.

What is the stock ticker of TriSalus Life Sciences, Inc. Common Stock?

TriSalus Life Sciences, Inc. Common Stock trades under the ticker TLSI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is TriSalus Life Sciences, Inc. Common Stock stock going up?

TLSI has changed by -8.87% over the last week, +11.29% over the last month, and -6.58% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of TriSalus Life Sciences, Inc. Common Stock?

TriSalus Life Sciences, Inc. Common Stock currently has a market capitalization of 297.41 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were TriSalus Life Sciences, Inc. Common Stock earnings last quarter?

Last quarter, TriSalus Life Sciences, Inc. Common Stock reported earnings of -0.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was TriSalus Life Sciences, Inc. Common Stock revenue for the last quarter?

TriSalus Life Sciences, Inc. Common Stock reported quarterly revenue of 11.41 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was TriSalus Life Sciences, Inc. Common Stock net income for the last quarter?

TriSalus Life Sciences, Inc. Common Stock reported net income of -9.19 M for the last quarter. The previous quarter showed 1.54 M, which means net income changed by -696.95%.

How many employees does TriSalus Life Sciences, Inc. Common Stock have?

As of the latest available data, TriSalus Life Sciences, Inc. Common Stock has 102 employees. Workforce size can provide additional context about the company's scale and operations.

What is TriSalus Life Sciences, Inc. Common Stock EBITDA?

TriSalus Life Sciences, Inc. Common Stock EBITDA is -9.62 M, and its EBITDA margin is -84.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy TriSalus Life Sciences, Inc. Common Stock stock?

You can buy TriSalus Life Sciences, Inc. Common Stock (TLSI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in TriSalus Life Sciences, Inc. Common Stock stock?

Investing in TriSalus Life Sciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TLSI chart and related analysis on metatrader.com as part of your research.

News